Literature DB >> 11931497

A prospective study of multiple supratherapeutic acetaminophen doses in febrile children.

Eran Kozer1, Joseph Barr, Mordechai Bulkowstein, Meytal Avgil, Revital Greenberg, Atalica Matias, Irena Petrov, Matitiahu Berkovitch.   

Abstract

Repeated doses of acetaminophen given for therapeutic reasons have been reported to cause hepatotoxicity in adults and children. We studied the effect of repeated acetaminophen (APAP) overdoses administered for therapeutic purposes in a prospective cohort of children. Forty-four children, aged 2 mo to 10 y were referred with a fever of >38.5 C for more than 48 h, and received >60 mg APAP/kg/d. In each patient AST, ALT and APAP blood levels were measured. The mean total daily dose of APAP was 92+/-26 (63-171) mg/kg. There was a weak, but significant, negative correlation between age and daily dose of APAP where younger children received higher doses of APAP. In 4 children (9.1%) an elevation of AST and ALT was found. Three of the 4 patients with elevated liver enzymes had received >90 mg APAP/kg/day; APAP blood levels ranged from 0 to 23 mg/mL. No correlation was found between the time since last APAP dose and the serum drug level. Ill children receiving repeated supratherapeutic doses of acetaminophen may show abnormalities in liver function. However, severe liver injury was rare.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931497

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  3 in total

1.  Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management.

Authors:  Maurizio de Martino; Alberto Chiarugi
Journal:  Pain Ther       Date:  2015-10-30

2.  Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen.

Authors:  Sibo Jiang; Valvanera Vozmediano; Susan M Abdel-Rahman; Stephan Schmidt; Laura P James
Journal:  J Clin Pharmacol       Date:  2019-05-17       Impact factor: 3.126

3.  Symptomatic fever management in children: A systematic review of national and international guidelines.

Authors:  Cari Green; Hanno Krafft; Gordon Guyatt; David Martin
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.